Tech Company Financing Transactions

Novelion Therapeutics Funding Round

Novelion Therapeutics closed a $17.6 million funding round on 12/31/2007. Investors included Advent International, Alta Partners and Hercules Technology Growth Capital.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

510 West Georgia St. 1800
Vancouver BC, V6B 0M3
USA

Phone

617-500-7867

Website

www.novelion.com

Email Address

[email protected]

Overview

Novelion Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sandford Smith

        

Chief Financial Officer

Michael Price

        

Chief Operating Officer

Jeffrey Hackman

        

VP - General Counsel

Ben Harshbarger

        

VP - Human Resources

Linda Buono

        

VP - R & D

Murray Stewart

        

Browse more venture capital transactions:

Prev: 12/31/2007: Glimmerglass Networks venture capital transaction
Next: 12/31/2007: Mail.com venture capital transaction

Share this article

News on VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary